Bharat Biotech has been granted permission to start the Phase III trials of Covaxin – India’s indigenous Covid-19 vaccine candidate. [REPRESENTATIVE IMAGE] File photo of Covaxin (Picture Courtesy: Twitter @airnewsalerts) The Drug Controller General of India (DGCI) on Thursday allowed Bharat Biotech International Limited to conduct the Phase III trials of its Covid-19 vaccine candidate … Read more
Lead researcher for the project Dr Chris Chiu, from Imperial College London, said: “My team has been safely running human challenge studies with other respiratory viruses for over 10 years. No study is completely risk free, but the Human Challenge Programme partners will be working hard to ensure we make the risks as low as … Read more
US pharma giant Pfizer, which is developing a potential coronavirus vaccine with BioNTech, has said it could have the vaccine in November. Pfizer Inc has announced that it could apply for US authorisation of the vaccine by November. Meanwhile, the Russian coronavirus vaccine (Sputnik V) that suffered a setback in India, may again resume the … Read more
The Indian Council of Medical Research (ICMR) has developed an ‘antisera’ for treatment of coronavirus and has been approved by the Drugs Controller General of India (DCGI) for clinical trials. The antisera has been developed by injecting the SARS-CoV-2 in animals. The antisera developed by ICMR and Hyderabad-based biopharmaceutical firm Biological E Ltd is an … Read more
Image copyright Novavax A trial of a new vaccine that appears to train the immune system to fight coronavirus has begun in the UK. Early tests showed the jab, developed by US biotechnology company Novavax, leads to high levels of virus-fighting antibodies being produced. The trial on 10,000 people will now see if the vaccine … Read more
Human challenge trials are regarded by some as a faster way to develop vaccines – but they come with big risks. Challenge trials have been used for hundreds of years but a lot of people question how ethical is to deliberately expose people to an infectious disease. More than 140 different organisations around the world … Read more
By Steven Reinberg HealthDay Reporter MONDAY, Aug. 17, 2020 (HealthDay News) — Although minorities are paying a disproportionate price in the rate of COVID-19 illnesses and deaths, they are underrepresented in clinical trials, a new study finds. The researchers call upon the government, medical journals and funders of research to make sure trials include minorities … Read more
Aug. 11, 2020 — Before completing clinical trials to ensure the vaccine is safe and effective, the Russian government has gone ahead and approved a vaccine against the new coronavirus, the New York Times reported Tuesday. According to Russian President Vladimir Putin, the vaccine works “effectively enough.” The premature approval of a vaccine … Read more